SCM
HALO icon

Stevens Capital Management’s Halozyme HALO Stock Holding History

Stevens Capital Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,309
Closed -$389K – 259
2025
Q3 		$389K Buy
5,309
+792
+18% +$52.6K 0.05% 177
2025
Q2 		$235K Buy
+4,517
New +$257K 0.06% 206
2015
Q4 		– Sell
-18,928
Closed -$254K – 1002
2015
Q3 		$254K Buy
+18,928
New +$380K 0.01% 755
2014
Q3 		– Sell
-12,480
Closed -$123K – 1100
2014
Q2 		$123K Sell
12,480
-2,890
-19% -$24.5K ﹤0.01% 987
2014
Q1 		$195K Buy
+15,370
New +$228K 0.01% 931

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Stevens Capital Management's HALO Position: Q4 2025 in Review

Stevens Capital Management sold out of Halozyme (HALO) in Q4 2025, closing a stake of 5,309 shares — an estimated $389K sold.

Stevens Capital Management first reported a position in HALO in Q1 2014 and held it in 5 quarters. The position peaked at $389K in Q3 2025. 617 funds tracked by Wall St. Rank hold HALO as of Q4 2025.

  • Stevens Capital Management reported no remaining Halozyme position as of Q4 2025 after selling out during the quarter.
  • Stevens Capital Management sold 5,309 Halozyme shares in Q4 2025, an estimated $389K.
  • Stevens Capital Management first reported a position in Halozyme in Q1 2014 and held it in 5 quarters.
  • Stevens Capital Management's Halozyme position peaked at $389K in Q3 2025.
  • 617 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.

Based on Stevens Capital Management's 13F filing for Q4 2025, filed 3 Feb 2026.